These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 18782803)

  • 1. [Anatomical and functional outcomes of the "3+PRN" therapeutic protocol in the treatment of diabetic macular edema].
    Ammari W; Chaabene H; Messaoud R
    J Fr Ophtalmol; 2024 Jun; 47(7):104234. PubMed ID: 38875945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two different treatment regimens' efficacy in neovascular age-related macular degeneration in Turkish population-based on real life data-Bosphorus RWE Study Group.
    Erden B; Bölükbaşı S; Özkaya A; Karabaş L; Alagöz C; Alkın Z; Artunay Ö; Bayramoğlu SE; Demir G; Demir M; Demircan A; Erdoğan G; Erdoğan M; Eriş E; Kaldırım H; Onur İU; Osmanbaşoğlu ÖA; Özdoğan Erkul S; Öztürk M; Perente İ; Sarıcı K; Sayın N; Yaşa D; Yılmaz İ; Yılmazabdurrahmanoğlu Z;
    Int J Ophthalmol; 2020; 13(1):104-111. PubMed ID: 31956577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-weekly bevacizumab versus 4-weekly ranibizumab for neovascular age-related macular degeneration: a 2-year outcome.
    Chiam PJ; Ho VW; Hickley NM; Kotamarthi V
    Int J Ophthalmol; 2016; 9(4):551-5. PubMed ID: 27162727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed Hospital Appointments of Patients Receiving Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.
    Karampelas M; Pefkianaki M; Rees A; Gill N; Kotecha A; Hamilton R; Nikita E; Patel PJ
    Ophthalmol Ther; 2015 Jun; 4(1):43-9. PubMed ID: 25769782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor in age-related macular degeneration: puzzle or a silent beginning!
    Natarajan S
    Indian J Ophthalmol; 2013 Sep; 61(9):475-8. PubMed ID: 24104704
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial).
    Menon G; Chandran M; Sivaprasad S; Chavan R; Narendran N; Yang Y
    Eye (Lond); 2013 Aug; 27(8):959-63. PubMed ID: 23743535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on different methods for the treatment of choroidal neovascularization. The efficacy of verteporfin photodynamic therapy, intravitreal bevacizumab and transpupillary thermotherapy in patients with neovascular age-related macular degeneration.
    Nowak MS; Jurowski P; Grzybowski A; Goś R; Pastuszka M; Kapica A; Śmigielski J
    Med Sci Monit; 2012 Jun; 18(6):CR374-80. PubMed ID: 22648253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy.
    Kim KS; Lee WK
    Jpn J Ophthalmol; 2011 Jul; 55(4):370-377. PubMed ID: 21647565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration.
    Kang S; Roh YJ
    Jpn J Ophthalmol; 2011 Mar; 55(2):123-7. PubMed ID: 21400056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.
    Ruiz-Moreno JM; Montero JA; Amat-Peral P
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):595-9. PubMed ID: 21234588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved assessment of laser-induced choroidal neovascularization.
    Toma HS; Barnett JM; Penn JS; Kim SJ
    Microvasc Res; 2010 Dec; 80(3):295-302. PubMed ID: 20553963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF therapies and blood pressure: more than meets the eye.
    Enseleit F; Michels S; Ruschitzka F
    Curr Hypertens Rep; 2010 Feb; 12(1):33-8. PubMed ID: 20425156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients.
    Suzuki M; Gomi F; Sawa M; Tsujikawa M; Sakaguchi H
    Jpn J Ophthalmol; 2010 Mar; 54(2):124-8. PubMed ID: 20401560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitions of multifocal electroretinography in patients with age-related macular degeneration after combination therapy with photodynamic therapy and intravitreal bevacizumab.
    Liu Y; Wen F; Li J; Zuo C; Li M
    Doc Ophthalmol; 2009 Dec; 119(3):163-9. PubMed ID: 20101800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Arias L; Caminal JM; Casas L; Masuet C; Badia MB; Rubio M; Pujol O; Arruga J
    Br J Ophthalmol; 2008 Dec; 92(12):1636-41. PubMed ID: 18782803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration.
    Gupta B; Adewoyin T; Patel SK; Sivaprasad S
    Br J Ophthalmol; 2011 Mar; 95(3):386-90. PubMed ID: 20693484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.